Format

Send to

Choose Destination
J Food Biochem. 2019 Apr;43(4):e12793. doi: 10.1111/jfbc.12793. Epub 2019 Jan 29.

Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation.

Author information

1
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
2
Research Center of Advanced Materials, King Khalid University, Abha, Saudi Arabia.

Abstract

Thymoquinone (Tq) is an active compound from Nigella sativa which is used in traditional medicine. The effect of Tq on kidney cancer and the pathway of action remain unproven. Herein, we report the anticancer properties of Tq on kidney cancer cells. Tq demonstrated anti-proliferative effects in A498 cells with a GI50 value of 40.07 µM and Caki-1 cells with a GI50 of 51.04 µM by the MTT assay. Tq exhibited nuclear fragmentation and inhibited trans-endothelial migration of A498 and Caki-1 cells in a dose-responsive manner. Time-dependent increase in Annexin V-positive cells and sub-G0 /G1 cell population was observed post-Tq treatment. The compound increased Bax protein levels and reduced Bcl-2 protein levels dose dependently in cells, thereby favoring apoptosis. Tq decreased the phosphorylation of Akt in both kidney cell types. The results suggest effective anticancer activity of Tq on kidney cancer cells which may be mediated by the Akt pathway. PRACTICAL APPLICATIONS: Results from the current investigation will through more light on the mechanistic pathway of Tq activity on the inhibition of kidney cancer cell proliferation. The output of this preclinical in vitro study may be translated into better chemotherapeutics of Tq and its analogs to treat kidney cancer. However, a detailed investigation on in vivo models is recommended.

KEYWORDS:

A498; Caki-1; apoptosis; cell cycle; pAkt; thymoquinone

PMID:
31353586
DOI:
10.1111/jfbc.12793

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center